Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
   PubMed Web of Science ®Google Scholar
• Feng M, Ho M. Glypican-3 antibodies: a new therapeutic target for liver cancer. FEBS Lett. 2014;588(2):377–382.
   PubMed Web of Science ®Google Scholar
• Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010;29(36):4989–5005.
   PubMed Web of Science ®Google Scholar
• Chun S, Rhie SY, Ki CS, et al. Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas. Ann Hepatol. 2015;14(6):882–888.
   PubMed Web of Science ®Google Scholar
• Lee J, Kim KW, Kim SY, et al. Automatic detection method of hepatocellular carcinomas using the non-rigid registration method of multi-phase liver CT images. J Xray Sci Technol. 2015;23(3):275–288.
   PubMed Web of Science ®Google Scholar
• Dai M, Chen X, Liu X, et al. Diagnostic value of the combination of Golgi Protein 73 and alpha-fetoprotein in hepatocellular carcinoma: a meta-analysis. PLOS ONE. 2015;10(10):e0140067.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Yeh SH, Chen JT, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology. 2000;119(2):431–440.
   PubMed Web of Science ®Google Scholar
• Li T, Xie J, Shen C, et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma. Oncogene. 2016;35(12):1575–1584.
   PubMed Web of Science ®Google Scholar
• Tan DSW, Chong FT, Leong HS, et al. Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma. Nat Med. 2017;23(10):1167–1175.
   PubMed Web of Science ®Google Scholar
• Xu Y, Ge Z, Zhang E, et al. The lncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3. Cell Death Dis. 2017;8(10):e3104.
   PubMed Web of Science ®Google Scholar
• Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25(5):666–681.
   PubMed Web of Science ®Google Scholar
• Bao H, Guo CG, Qiu PC, et al. Long non-coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway. Oncol Lett. 2017;14(3):2831–2837.
   PubMed Web of Science ®Google Scholar
• Zhong XM, Cai Y. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway. Bioengineered. 2021;12:9113–9127.
   PubMed Web of Science ®Google Scholar
• Ren JY, Xu N, Zhou RZ, et al. Long non-coding RNA PCED1B antisense RNA 1 promotes gastric cancer progression via modulating microRNA-215-3p/C-X-C motif chemokine receptor 1 axis. Bioengineered. 2021;12:6083–6095.
   PubMed Web of Science ®Google Scholar
• Xing Z, Zhang Z, Gao Y, et al. The lncRNA LINC01194/miR-486-5p axis facilitates malignancy in non-small cell lung cancer via regulating CDK4. Onco Targets Ther. 2020;13:3151–3163.
   PubMed Web of Science ®Google Scholar
• Shi Y, Fang N, Li Y, et al. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci. 2020;111(8):2824–2836.
   PubMed Web of Science ®Google Scholar
• Bandiera S, Pfeffer S, Baumert TF. Zeisel MB. miR-122–a key factor and therapeutic target in liver disease. J Hepatol. 2015;62(2):448–457.
   PubMed Web of Science ®Google Scholar
• Elton TS, Selemon H, Elton SM, et al. Regulation of the MIR155 host gene in physiological and pathological processes. Gene. 2013;532(1):1–12.
   PubMed Web of Science ®Google Scholar
• Zhang B, Sun YF, Zhang XM, et al. TUG1 weakens the sensitivity of acute myeloid leukemia cells to cytarabine by regulating miR-655-3p/CCND1 axis. Eur Rev Med Pharmacol Sci. 2020;24(9):4940–4953.
   PubMed Web of Science ®Google Scholar
• Xin J, Zhao YH, Zhang XY, et al. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis. Hum Cell. 2020;33(4):1273–1280.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Xu YF, Fu Z, Gao XX, et al. Long non-coding RNA XIST promotes retinoblastoma cell proliferation, migration, and invasion by modulating microRNA-191-5p/brain derived neurotrophic factor. Bioengineered. 2021;12:1587–1598.
   PubMed Web of Science ®Google Scholar
• Telford WG. Multiparametric analysis of apoptosis by flow cytometry. Methods Mol Biol. 2018;1678:167–202.
   PubMedGoogle Scholar
• Han D, Yu ZJ, Zhang H, et al. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry. Bioengineered. 2021;12:10891–10904.
   PubMed Web of Science ®Google Scholar
• Yu L, Qu H, Yu Y, et al. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med. 2018;22:6134–6147.
   PubMed Web of Science ®Google Scholar
• Rathinasamy B, Velmurugan BK. Role of lncRNAs in the cancer development and progression and their regulation by various phytochemicals. Biomed Pharmacother. 2018;102:242–248.
   PubMed Web of Science ®Google Scholar
• Lai XN, Li J, Tang LB, et al. miRNAs and LncRNAs: dual roles in TGF-β signaling-regulated metastasis in lung cancer. Int J Mol Sci. 2020;21(4). DOI:10.3390/ijms21041193
   Web of Science ®Google Scholar
• Chen Z, Yu C, Zhan L, et al. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384. Am J Cancer Res. 2016;6(10):2299–2309.
   PubMed Web of Science ®Google Scholar
• She K, Huang J, Zhou H, et al. lncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression. Oncol Rep. 2016;36(5):2673–2680.
   PubMed Web of Science ®Google Scholar
• Han F, Wang C, Wang Y, et al. Long noncoding RNA ATB promotes osteosarcoma cell proliferation, migration and invasion by suppressing miR-200s. Am J Cancer Res. 2017;7(4):770–783.
   PubMed Web of Science ®Google Scholar
• Pan WD, Li W, Zhao J, et al. LncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/caspase 3 pathway. Mol Oncol. 2019;13(10):2246–2258.
   PubMed Web of Science ®Google Scholar
• Chao YJ, Zhou DJ. LncRNA-D16366 is a potential biomarker for diagnosis and prognosis of hepatocellular carcinoma. Med Sci Monit. 2019;25:6581–6586.
   PubMed Web of Science ®Google Scholar
• Linc WX. 01194 Acts as an oncogene in colorectal carcinoma and is associated with poor survival outcome. Cancer Manag Res. 2019;11:2349–2362.
   PubMed Web of Science ®Google Scholar
• Liu DM, Yang H, Yuan ZN, et al. Long noncoding RNA LINC01194 enhances the malignancy of laryngeal squamous cell carcinoma by sponging miR-655 to increase SOX18 expression. Biochem Biophys Res Commun. 2020;529(2):148–155.
   PubMed Web of Science ®Google Scholar
• Song HR, Guo XB, Duan Y, et al. PAX5-induced upregulation of LINC01194 exerts oncogenic properties by regulating GOLPH3 expression via miR-486-5p in prostate cancer. Eur Rev Med Pharmacol Sci. 2021;25(6):2528–2541.
   PubMed Web of Science ®Google Scholar
• Luo HR, Xu CD, Le W, et al. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493.
   PubMed Web of Science ®Google Scholar
• He JH, Han ZP, Zou MX, et al. Analyzing the LncRNA, miRNA, and mRNA regulatory network in prostate cancer with bioinformatics software. J Comput Biol. 2018;25(2):146–157.
   PubMed Web of Science ®Google Scholar
• Wang W, Cao RH, Su WY, et al. miR-655-3p inhibits cell migration and invasion by targeting pituitary tumor-transforming 1 in non-small cell lung cancer. Biosci Biotechnol Biochem. 2019;83(9):1703–1708.
   PubMed Web of Science ®Google Scholar
• Zha JF, Chen DX. miR-655-3p inhibited proliferation and migration of ovarian cancer cells by targeting RAB1A. Eur Rev Med Pharmacol Sci. 2019;23(9):3627–3634.
   PubMed Web of Science ®Google Scholar
• Chen YS, Xu YP, Liu WH, et al. Long noncoding RNA KCNMB2-AS1 promotes SMAD5 by targeting miR-3194-3p to induce bladder cancer progression. Front Oncol. 2021;11:649778.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Gan HY, Song WQ, et al. MicroRNA-145 promotes esophageal cancer cells proliferation and metastasis by targeting SMAD5. Scand J Gastroenterol. 2018;53(7):769–776.
   PubMed Web of Science ®Google Scholar